Publications

  1. Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang LS, Kauwe JS, Huentelman MJ, Myers AJ, Bird TD, Boeve BF, Baldwin CT, Jarvik GP, Crane PK, Rogaeva E, Barmada MM, Demirci FY, Cruchaga C, Kramer PL, Effects of Multiple Genetic Loci on Age at Onset in Late-Onset Alzheimer Disease: A Genome-Wide Association Study. JAMA Neurol. 2014 Sep 08.
    View PubMed
  2. Fatourechi V, Morris JC 3rd, Sebo TJ. Coexistence of radioactive iodine-resistant benign struma ovarii with cervical primary papillary cancer of the thyroid: an unusual cause of thyroglobulin-positive radioactive iodine-negative whole-body scans. Thyroid. 2014 Sep; 24(9):1432-4. Epub 2014 Jul 14.
    View PubMed
  3. Spitzweg C, Bible KC, Hofbauer LC, Morris JC. Advanced radioiodine-refractory differentiated thyroid cancer: the sodium iodide symporter and other emerging therapeutic targets. Lancet Diabetes Endocrinol. 2014 May 30.
    View PubMed
  4. Bible KC, Suman VJ, Molina JR, Smallridge RC, Maples WJ, Menefee ME, Rubin J, Karlin N, Sideras K, Morris JC 3rd, McIver B, Hay I, Fatourechi V, Burton JK, Webster KP, Bieber C, Traynor AM, Flynn PJ, Cher Goh B, Isham CR, Harris P, Erlichman C, Endocrine A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H. J Clin Endocrinol Metab. 2014 May; 99(5):1687-93. Epub 2014 Feb 25.
    View PubMed
  5. Brito JP, Gionfriddo MR, Al Nofal A, Boehmer KR, Leppin AL, Reading C, Callstrom M, Elraiyah TA, Prokop LJ, Stan MN, Murad MH, Morris JC, Montori VM. The accuracy of thyroid nodule ultrasound to predict thyroid cancer: systematic review and meta-analysis. J Clin Endocrinol Metab. 2014 Apr; 99(4):1253-63. Epub 2013 Nov 25.
    View PubMed
  6. Brito JP, Gionfriddo M, Morris JC, Montori VM. Overdiagnosis of thyroid cancer and graves' disease. Thyroid. 2014 Feb; 24(2):402-3. Epub 2013 Nov 14.
    View PubMed
  7. Brito JP, Hay ID, Morris JC. Low risk papillary thyroid cancer. BMJ. 2014; 348:g3045. Epub 2014 Jun 16.
    View PubMed
  8. Castro MR, Thomas BC, Richards ML, Zhang J, Morris JC. Multiple endocrine neoplasia type 2A due to an exon 8 (G533C) mutation in a large North American kindred. Thyroid. 2013 Dec; 23(12):1547-52. Epub 2013 Jul 25.
    View PubMed
  9. Trujillo MA, Oneal MJ, McDonough SJ, Morris JC. Viral dose, radioiodide uptake, and delayed efflux in adenovirus-mediated NIS radiovirotherapy correlates with treatment efficacy. Gene Ther. 2013 May; 20(5):567-74. Epub 2012 Sep 13.
    View PubMed
  10. Alizad A, Urban MW, Morris JC, Reading CC, Kinnick RR, Greenleaf JF, Fatemi M. In vivo thyroid vibro-acoustography: a pilot study. BMC Med Imaging. 2013; 13:12. Epub 2013 Mar 27.
    View PubMed
  11. Brito JP, Morris JC, Montori VM. Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours. BMJ. 2013; 347:f4706. Epub 2013 Aug 27.
    View PubMed
  12. Trujillo MA, Oneal MJ, McDonough S, Qin R, Morris JC. A steep radioiodine dose response scalable to humans in sodium-iodide symporter (NIS)-mediated radiovirotherapy for prostate cancer. Cancer Gene Ther. 2012 Dec; 19(12):839-44. Epub 2012 Oct 05.
    View PubMed
  13. Reddi HV, Madde P, McDonough SJ, Trujillo MA, Morris JC 3rd, Myers RM, Peng KW, Russell SJ, McIver B, Eberhardt NL. Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy. Cancer Gene Ther. 2012 Sep; 19(9):659-65. Epub 2012 Jul 13.
    View PubMed
  14. Oneal MJ, Trujillo MA, Davydova J, McDonough S, Yamamoto M, Morris JC 3rd. Characterization of infectivity-enhanced conditionally replicating adenovectors for prostate cancer radiovirotherapy. Hum Gene Ther. 2012 Sep; 23(9):951-9. Epub 2012 Aug 22.
    View PubMed
  15. Bible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, Rubin J, Menefee ME, Sideras K, Maples WJ, McIver B, Fatourechi V, Hay I, Foote RL, Garces YI, Kasperbauer JL, Thompson GB, Grant CS, Richards ML, Sebo T, Lloyd R, Eberhardt NL, Reddi Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers. Am J Manag Care. 2012 May; 18(5):e162-7. Epub 2012 May 01.
    View PubMed
  16. Bible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, Rubin J, Menefee ME, Sideras K, Maples WJ, McIver B, Fatourechi V, Hay I, Foote RL, Garces YI, Kasperbauer JL, Thompson GB, Grant CS, Richards ML, Sebo T, Lloyd R, Eberhardt NL, Reddi HV Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers. J Oncol Pract. 2012 May; 8(3 Suppl):e1s-5s.
    View PubMed
  17. Ahmed KA, Davis BJ, Wilson TM, Wiseman GA, Federspiel MJ, Morris JC. Progress in gene therapy for prostate cancer. Front Oncol. 2012; 2:172. Epub 2012 Nov 19.
    View PubMed
  18. Castro MR, Espiritu RP, Bahn RS, Henry MR, Gharib H, Caraballo PJ, Morris JC. Predictors of malignancy in patients with cytologically suspicious thyroid nodules. Thyroid. 2011 Nov; 21(11):1191-8. Epub 2011 Oct 18.
    View PubMed
  19. Dwyer RM, Ryan J, Havelin RJ, Morris JC, Miller BW, Liu Z, Flavin R, O'Flatharta C, Foley MJ, Barrett HH, Murphy JM, Barry FP, O'Brien T, Kerin MJ. Mesenchymal Stem Cell-mediated delivery of the sodium iodide symporter supports radionuclide imaging and treatment of breast cancer. Stem Cells. 2011 Jul; 29(7):1149-57.
    View PubMed
  20. Foote RL, Molina JR, Kasperbauer JL, Lloyd RV, McIver B, Morris JC, Grant CS, Thompson GB, Richards ML, Hay ID, Smallridge RC, Bible KC. Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: a single-institution experience using aggressive multimodal therapy. Thyroid. 2011 Jan; 21(1):25-30. Epub 2010 Dec 16.
    View PubMed
  21. Ryan J, Curran CE, Hennessy E, Newell J, Morris JC, Kerin MJ, Dwyer RM. The sodium iodide symporter (NIS) and potential regulators in normal, benign and malignant human breast tissue. PLoS One. 2011; 6(1):e16023. Epub 2011 Jan 19.
    View PubMed
  22. Trujillo MA, Oneal MJ, McDonough S, Qin R, Morris JC. A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancer. Gene Ther. 2010 Nov; 17(11):1325-32. Epub 2010 Apr 29.
    View PubMed
  23. Bible KC, Suman VJ, Molina JR, Smallridge RC, Maples WJ, Menefee ME, Rubin J, Sideras K, Morris JC 3rd, McIver B, Burton JK, Webster KP, Bieber C, Traynor AM, Flynn PJ, Goh BC, Tang H, Ivy SP, Erlichman C, Endocrine Malignancies Disease Oriented Group, Ma Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study. Lancet Oncol. 2010 Oct; 11(10):962-72. Epub 2010 Sep 17
    View PubMed
  24. Spitzweg C, Morris JC. Genetics and phenomics of hypothyroidism and goiter due to NIS mutations. Mol Cell Endocrinol. 2010 Jun 30; 322(1-2):56-63. Epub 2010 Feb 12.
    View PubMed
  25. Weiner MW, Aisen PS, Jack CR Jr, Jagust WJ, Trojanowski JQ, Shaw L, Saykin AJ, Morris JC, Cairns N, Beckett LA, Toga A, Green R, Walter S, Soares H, Snyder P, Siemers E, Potter W, Cole PE, Schmidt M, Alzheimer's Disease Neuroimaging Initiative. The Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimers Dement. 2010 May; 6(3):202-11.e7.
    View PubMed
  26. Aisen PS, Petersen RC, Donohue MC, Gamst A, Raman R, Thomas RG, Walter S, Trojanowski JQ, Shaw LM, Beckett LA, Jack CR Jr, Jagust W, Toga AW, Saykin AJ, Morris JC, Green RC, Weiner MW, Alzheimer's Disease Neuroimaging Initiative. Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans. Alzheimers Dement. 2010 May; 6(3):239-46.
    View PubMed
  27. Msaouel P, Iankov ID, Allen C, Aderca I, Federspiel MJ, Tindall DJ, Morris JC, Koutsilieris M, Russell SJ, Galanis E. Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporter. Mol Ther. 2009 Dec; 17(12):2041-8. Epub 2009 Sep 22.
    View PubMed
  28. Morris JC. How do you approach the problem of TSH elevation in a patient on high-dose thyroid hormone replacement? Clin Endocrinol (Oxf). 2009 May; 70(5):671-3. Epub 2009 Feb 17.
    View PubMed
  29. Msaouel P, Iankov ID, Allen C, Morris JC, von Messling V, Cattaneo R, Koutsilieris M, Russell SJ, Galanis E. Engineered measles virus as a novel oncolytic therapy against prostate cancer. Prostate. 2009 Jan 1; 69(1):82-91.
    View PubMed
  30. Msaouel P, Iankov ID, Allen C, Morris JC, von Messling V, Cattaneo R, Koutsilieris M, Russell SJ, Galanis E. Engineered measles virus as a novel oncolytic therapy against prostate cancer. Prostate. 2009 Jan 1; 69(1):82-91.
    View PubMed
  31. Trujillo MA, Oneal MJ, Davydova J, Bergert E, Yamamoto M, Morris JC 3rd. Construction of an MUC-1 promoter driven, conditionally replicating adenovirus that expresses the sodium iodide symporter for gene therapy of breast cancer. Breast Cancer Res. 2009; 11(4):R53. Epub 2009 Jul 27.
    View PubMed
  32. Willhauck MJ, Samani BR, Wolf I, Senekowitsch-Schmidtke R, Stark HJ, Meyer GJ, Knapp WH, Goke B, Morris JC, Spitzweg C. The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer. Eur J Nucl Med Mol Imaging. 2008 Jul; 35(7):1272-81. Epub 2008 Apr 11.
    View PubMed
  33. Willhauck MJ, Sharif-Samani B, Senekowitsch-Schmidtke R, Wunderlich N, Goke B, Morris JC, Spitzweg C. Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone. Breast Cancer Res Treat. 2008 May; 109(2):263-72. Epub 2007 Jul 18.
    View PubMed
  34. Khoo TK, Baker CH, Hallanger-Johnson J, Tom AM, Grant CS, Reading CC, Sebo TJ, Morris JC 3rd. Comparison of ultrasound-guided fine-needle aspiration biopsy with core-needle biopsy in the evaluation of thyroid nodules. Endocr Pract. 2008 May-Jun; 14(4):426-31.
    View PubMed
  35. Willhauck MJ, Sharif Samani BR, Klutz K, Cengic N, Wolf I, Mohr L, Geissler M, Senekowitsch-Schmidtke R, Goke B, Morris JC, Spitzweg C. Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma. Gene Ther. 2008 Feb; 15(3):214-23. Epub 2007 Nov 8
    View PubMed
  36. Rao VP, Miyagi N, Ricci D, Carlson SK, Morris JC 3rd, Federspiel MJ, Bailey KR, Russell SJ, McGregor CG. Sodium iodide symporter (hNIS) permits molecular imaging of gene transduction in cardiac transplantation. Transplantation. 2007 Dec 27; 84(12):1662-6.
    View PubMed
  37. Willhauck MJ, Samani BRS, Gildehaus FJ, Wolf I, Senekowitsch-Schmidtke R, Stark HJ, Goke B, Morris JC, Spitzweg C. Application of (188)Rhenium as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expression. Journal of Clinical Endocrinology & Metabolism. 2007 Nov; 92(11):4451-8.
    View PubMed
  38. Spitzweg C, Baker CH, Bergert ER, O'Connor MK, Morris JC. Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression. Hum Gene Ther. 2007 Oct; 18(10):916-24.
    View PubMed
  39. Dingli D, Russell SJ, Morris JC. Reporting transgene expression using NIS. J Cell Biochem. 2007.
  40. Dwyer RM, Bergert ER, O'Connor MK, Gendler SJ, Morris JC. Adenovirus-mediated and targeted expression of the sodium-iodide symporter permits in vivo radioiodide imaging and therapy of pancreatic tumors. Hum Gene Ther. 2006 Jun; 17(6):661-8.
    View PubMed
  41. Unterholzner S, Willhauck MJ, Cengic N, Schutz M, Goke B, Morris JC, Spitzweg C. Dexamethasone stimulation of retinoic Acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells. J Clin Endocrinol Metab. 2006 Jan; 91(1):69-78. Epub 2005 Oct 18.
    View PubMed
  42. Dwyer RM, Bergert ER, O'Connor MK, Gendler SJ, Morris JC. Sodium iodide symporter-mediated radioiodide imaging and therapy of ovarian tumor xenografts in mice. Gene Ther. 2006 Jan; 13(1):60-6.
    View PubMed
  43. Dingli D, Kemp BJ, O'Connor MK, Morris JC, Russell SJ, Lowe VJ. Combined I-124 positron emission tomography/computed tomography imaging of NIS gene expression in animal models of stably transfected and intravenously transfected tumor. Mol Imaging Biol. 2006 Jan-Feb; 8(1):16-23.
    View PubMed
  44. Stan M, Morris JC. Thyrotropin-axis adaptation in aging and chronic disease. Endocrinol Metab Clin North Am. 2005 Dec; 34(4):973-92, x.
    View PubMed
  45. Dingli D, Peng KW, Harvey ME, Vongpunsawad S, Bergert ER, Kyle RA, Cattaneo R, Morris JC, Russell SJ. Interaction of measles virus vectors with Auger electron emitting radioisotopes. Biochem Biophys Res Commun. 2005 Nov 11; 337(1):22-9.
    View PubMed
  46. Dwyer RM, Schatz SM, Bergert ER, Myers RM, Harvey ME, Classic KL, Blanco MC, Frisk CS, Marler RJ, Davis BJ, O'Connor MK, Russell SJ, Morris JC. A preclinical large animal model of adenovirus-mediated expression of the sodium-iodide symporter for radioiodide imaging and therapy of locally recurrent prostate cancer. Mol Ther. 2005 Nov; 12(5):835-41. Epub 2005 Jul 27.
    View PubMed
  47. Cengic N, Baker CH, Schutz M, Goke B, Morris JC, Spitzweg C. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression. J Clin Endocrinol Metab. 2005 Aug; 90(8):4457-64.
    View PubMed
  48. Dwyer RM, Bergert ER, O'Connor MK, Gendler SJ, Morris JC. In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter. Clin Cancer Res. 2005 Feb 15; 11(4):1483-9.
    View PubMed
  49. Scholz IV, Cengic N, Baker CH, Harrington KJ, Maletz K, Bergert ER, Vile R, Goke B, Morris JC, Spitzweg C. Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer. Gene Ther. 2005 Feb; 12(3):272-80.
    View PubMed
  50. Dingli D, Bergert ER, Bajzer Z, O'connor MK, Russell SJ, Morris JC. Dynamic iodide trapping by tumor cells expressing the thyroidal sodium iodide symporter. Biochem Biophys Res Commun. 2004 Dec 3; 325(1):157-66.
    View PubMed
  51. Baker CH, Morris JC. The sodium-iodide symporter. Current Drug Targets - Immune Endocrine & Metabolic Disorders. 2004 Sep; 4(3):167-74.
    View PubMed
  52. Guo J, Pichurin PN, Morris JC, Rapoport B, McLachlan SM. Naked deoxyribonucleic acid vaccination induces recognition of diverse thyroid peroxidase T cell epitopes. Endocrinology. 2004 Aug; 145(8):3671-8. Epub 2004 May 03.
    View PubMed
  53. Spitzweg C, Morris JC. Gene therapy for thyroid cancer: Current status and future prospects. Thyroid. 2004 Jun; 14(6):424-34.
    View PubMed
  54. Dingli D, Peng KW, Harvey ME, Greipp PR, O'Connor MK, Cattaneo R, Morris JC, Russell SJ. Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter. Blood. 2004 Mar 1; 103(5):1641-6. Epub 2003 Nov 06.
    View PubMed
  55. Scholz IV, Cengic N, Goke B, Morris JC, Spitzweg C. Dexamethasone enhances the cytotoxic effect of radioiodine therapy in prostate cancer cells expressing the sodium iodide symporter. J Clin Endocrinol Metab. 2004 Mar; 89(3):1108-16.
    View PubMed
  56. Fatourechi V, Klee GG, Grebe SK, Bahn RS, Brennan MD, Hay ID, McIver B, Morris JC. Effects of reducing the upper limit of normal TSH values. JAMA: Journal of the American Medical Association. 2003 Dec 24; 290(24):3195-6.
    View PubMed
  57. Dingli D, Russell SJ, Morris JC 3rd. In vivo imaging and tumor therapy with the sodium iodide symporter. J Cell Biochem. 2003 Dec 15; 90(6):1079-86.
    View PubMed
  58. Kakinuma H, Bergert ER, Spitzweg C, Cheville JC, Lieber MM, Morris JC. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer. Cancer Res. 2003 Nov 15; 63(22):7840-4.
    View PubMed
  59. Dobert N, Hamscho N, Bergert ER, Oeschger S, Berner U, Goellner J, Menzel C, Morris JC, Grunwald F. Pancreatic carcinoma with positive iodine uptake lacking NIS-protein-expression. Nuklearmedizin. 2003 Aug; 42(4):N42-4.
    View PubMed
  60. Spitzweg C, Scholz IV, Bergert ER, Tindall DJ, Young CYF, Goke B, Morris JC. Retinoic acid-induced stimulation of sodium iodide symporter expression and cytotoxicity of radioiodine in prostate cancer cells. Endocrinology. 2003 Aug; 144(8):3423-32.
    View PubMed
  61. Dingli D, Diaz RM, Bergert ER, O'Connor MK, Morris JC, Russell SJ. Genetically targeted radiotherapy for multiple myeloma. Blood. 2003 Jul 15; 102(2):489-96. Epub 2003 Mar 20.
    View PubMed
  62. Preissner CM, O'Kane DJ, Singh RJ, Morris JC, Grebe SKG. Phantoms in the assay tube: Heterophile antibody interferences in serum thyroglobulin assays. J Clin Endocrinol Metab. 2003 Jul; 88(7):3069-74.
    View PubMed
  63. Schwarz-Lauer L, Pichurin PN, Chen CR, Nagayama Y, Paras C, Morris JC, Rapoport B, McLachlan SM. The cysteine-rich amino terminus of the thyrotropin receptor is the immunodominant linear antibody epitope in mice immunized using naked deoxyribonucleic acid or adenovirus vectors. Endocrinology. 2003 May; 144(5):1718-25.
    View PubMed
  64. Spitzweg C, Morris JC. The sodium iodide symporter: its pathophysiological and therapeutic implications [Review]. Clin Endocrinol (Oxf) 2002 Nov; 57(5):559-74.
    View PubMed
  65. Pichurin P, Schwarz-Lauer L, Braley-Mullen H, Paras C, Pichurina O, Morris JC, Rapoport B, McLachlan SM. Peptide scanning for thyrotropin receptor T-cell epitopes in mice vaccinated with naked DNA. Thyroid. 2002 Sep; 12(9):755-64.
    View PubMed
  66. Castro MR, Caraballo PJ, Morris JC. Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. J Clin Endocrinol Metab. 2002 Sep; 87(9):4154-9.
    View PubMed
  67. Morris JC. Surgical treatment of inflammatory disease of the thyroid. Endocr Pract. 2002; 8(4):313-4.
    View PubMed
  68. Spitzweg C, Morris JC. Sodium Iodide Symporter (NIS) and thyroid. Hormone. 2002; 1:22-34.
  69. Castro MR, Bergert ER, Goellner JR, Hay ID, Morris JC. Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake. J Clin Endocrinol Metab. 2001 Nov; 86(11):5627-32.
    View PubMed
  70. Spitzweg C, Dietz AB, O'Connor MK, Bergert ER, Tindall DJ, Young CY, Morris JC. In vivo sodium iodide symporter gene therapy of prostate cancer. Gene Ther. 2001 Oct; 8(20):1524-31.
    View PubMed
  71. Pinke LA, Dean DS, Bergert ER, Spitzweg C, Dutton CM, Morris JC. Cloning of the mouse sodium iodide symporter. Thyroid. 2001 Oct; 11(10):935-9.
    View PubMed
  72. Harrington KJ, Spitzweg C, Bateman AR, Morris JC, Vile RG. Gene therapy for prostate cancer: current status and future prospects. J Urol. 2001 Oct; 166(4):1220-33.
    View PubMed
  73. Smallridge RC, Castro MR, Morris JC, Young PR, Reynolds JC, Merino MJ, Sarlis NJ. Renal metastases from thyroid papillary carcinoma: study of sodium iodide symporter expression. Thyroid. 2001 Aug; 11(8):795-804.
    View PubMed
  74. Spitzweg C, Harrington KJ, Pinke LA, Vile RG, Morris JC. Clinical review 132: The sodium iodide symporter and its potential role in cancer therapy. J Clin Endocrinol Metab. 2001 Jul; 86(7):3327-35.
    View PubMed
  75. Graves JW, Morris JC, Sheps SG. Martorell's hypertensive leg ulcer: case report and concise review of the literature. J Hum Hypertens. 2001 Apr; 15(4):279-83.
    View PubMed
  76. Spitzweg C, Dutton CM, Castro MR, Bergert ER, Goellner JR, Heufelder AE, Morris JC. Expression of the sodium iodide symporter in human kidney. Kidney Int. 2001 Mar; 59(3):1013-23.
    View PubMed
  77. Mitchell AM, Manley SW, Morris JC, Powell KA, Bergert ER, Mortimer RH. Sodium iodide symporter (NIS) gene expression in human placenta. Placenta. 2001 Feb-Mar; 22(2-3):256-8.
    View PubMed
  78. Vella A, Nippoldt TB, Morris JC 3rd. Adrenal hemorrhage: a 25-year experience at the Mayo Clinic. Mayo Clin Proc. 2001 Feb; 76(2):161-8.
    View PubMed
  79. Spitzweg C, Bergert ER, Morris JC. Sodium iodide symporter: Its biology, clinical relevance, and potential role in the pathophysiology of autoimmune thyroid disease. Current Opinion in Endocrinology & Diabetes. 2001; 8(5):259-265.
  80. Spitzweg C, Morris JC. Approaches to gene therapy with sodium/iodide symporter. Exp Clin Endocrinol Diabetes. 2001; 109(1):56-9.
    View PubMed
  81. Spitzweg C, O'Connor MK, Bergert ER, Tindall DJ, Young CY, Morris JC. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter. Cancer Res. 2000 Nov 15; 60(22):6526-30.
    View PubMed
  82. Spitzweg C, Morris JC. The immune response to the iodide transporter. Endocrinol Metab Clin North Am. 2000 Jun; 29(2):389-98, viii.
    View PubMed
  83. Spitzweg C, Heufelder AE, Morris JC. Thyroid iodine transport. Thyroid. 2000 Apr; 10(4):321-30.
    View PubMed
  84. Castro MR, Kocher D, Morris JC. An unusual case of inappropriate secretion of thyrotropin: neoplastic or nonneoplastic? Endocr Pract. 2000 Jan-Feb; 6(1):29-33.
    View PubMed
  85. Castro MR, Bergert ER, Beito TG, Roche PC, Ziesmer SC, Jhiang SM, Goellner JR, Morris JC. Monoclonal antibodies against the human sodium iodide symporter: utility for immunocytochemistry of thyroid cancer. J Endocrinol. 1999 Dec; 163(3):495-504.
    View PubMed
  86. Spitzweg C, Joba W, Schriever K, Goellner JR, Morris JC, Heufelder AE. Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands. J Clin Endocrinol Metab. 1999 Nov; 84(11):4178-84.
    View PubMed
  87. Gabriel EM, Bergert ER, Grant CS, van Heerden JA, Thompson GB, Morris JC. Germline polymorphism of codon 727 of human thyroid-stimulating hormone receptor is associated with toxic multinodular goiter. J Clin Endocrinol Metab. 1999 Sep; 84(9):3328-35.
    View PubMed
  88. Castro MR, Bergert ER, Beito TG, McIver B, Goellner JR, Morris JC. Development of monoclonal antibodies against the human sodium iodide symporter: immunohistochemical characterization of this protein in thyroid cells. J Clin Endocrinol Metab. 1999 Aug; 84(8):2957-62.
    View PubMed
  89. Spitzweg C, Joba W, Morris JC, Heufelder AE. Regulation of sodium iodide symporter gene expression in FRTL-5 rat thyroid cells. Thyroid. 1999 Aug; 9(8):821-30.
    View PubMed
  90. Spitzweg C, Zhang S, Bergert ER, Castro MR, McIver B, Heufelder AE, Tindall DJ, Young CY, Morris JC. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines. Cancer Res. 1999 May 1; 59(9):2136-41.
    View PubMed
  91. Morris JC. The clinical expression of thyrotropin receptor mutations. Endocrinologist. 1998 May; 8(3):195-201.
  92. McIver B, Morris JC. The pathogenesis of Graves' disease. Endocrinol Metab Clin North Am. 1998 Mar; 27(1):73-89.
    View PubMed
  93. Raju R, Navaneetham D, Kellermann SA, Freeman SL, Morris JC, McCormick DJ, Conti-Fine BM. TCR vbeta usage of TSH receptor-specific CD4+ T cells in Graves' disease patients and healthy humans. J Autoimmun. 1997 Oct; 10(5):479-89.
    View PubMed
  94. Morris JC, Bergert ER, Bryant WP. Binding of immunoglobulin G from patients with autoimmune thyroid disease to rat sodium-iodide symporter peptides: evidence for the iodide transporter as an autoantigen. Thyroid. 1997 Aug; 7(4):527-34.
    View PubMed
  95. Fu AZ, Morris JC, Ford GC, Nair KS. Sequential purification of human apolipoprotein B-100, albumin, and fibrinogen by immunoaffinity chromatography for measurement of protein synthesis. Anal Biochem. 1997 May 1; 247(2):228-36.
    View PubMed
  96. Campbell RK, Bergert ER, Wang Y, Morris JC, Moyle WR. Chimeric proteins can exceed the sum of their parts: implications for evolution and protein design. Nat Biotechnol. 1997 May; 15(5):439-43.
    View PubMed
  97. Morris JC. Structure and function of the TSH receptor: its suitability as a target for radiotherapy. Thyroid. 1997 Apr; 7(2):253-8.
    View PubMed
  98. McDonald ML, Daly RC, Schaff HV, Mullany CJ, Miller FA, Morris JJ, Orszulak TA. Hemodynamic performance of small aortic valve bioprostheses: is there a difference? Ann Thorac Surg. 1997 Feb; 63(2):362-6.
    View PubMed
  99. Odell JA, Mullany CJ, Schaff HV, Orszulak TA, Daly RC, Morris JJ. Aortic valve replacement after previous coronary artery bypass grafting. Ann Thorac Surg. 1996 Nov; 62(5):1424-30.
    View PubMed
  100. Porrata LF, Morris JC 3rd. 63-year-old woman with fever and right flank pain. Mayo Clin Proc. 1996 Oct; 71(10):1011-4.
    View PubMed
  101. Dallas JS, Cunningham SJ, Patibandla SA, Seetharamaiah GS, Morris JC, Tahara K, Kohn LD, Prabhakar BS. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding. Endocrinology. 1996 Aug; 137(8):3329-39.
    View PubMed
  102. Gehlot A, Mullany CJ, Ilstrup D, Schaff HV, Orzulak TA, Morris JJ, Daly RC. Aortic valve replacement in patients aged eighty years and older: early and long-term results. J Thorac Cardiovasc Surg. 1996 May; 111(5):1026-36.
    View PubMed
  103. Robinson BL, Morita T, Fujita K, Chow M, Schaff HV, Morris JJ. Bypass conduit vessel wall biology substantially influences downstream myocardial contractile response to injury from ischemia and reperfusion. J Thorac Cardiovasc Surg. 1996 Jan; 111(1):62-73.
    View PubMed
  104. Kellermann SA, McCormick DJ, Freeman SL, Morris JC, Conti-Fine BM. TSH receptor sequences recognized by CD4+ T cells in Graves' disease patients and healthy controls. J Autoimmun. 1995 Oct; 8(5):685-98.
    View PubMed
  105. Vlase H, Nakashima M, Graves PN, Tomer Y, Morris JC, Davies TF. Defining the major antibody epitopes on the human thyrotropin receptor in immunized mice: evidence for intramolecular epitope spreading. Endocrinology. 1995 Oct; 136(10):4415-23.
    View PubMed
  106. Sheehan MT, Morbeck DE, Bergert ER, McCormick DJ, Milius RP, Morris JC. Receptor-specific activity of heteromeric thyrotropin (TSH) analogs: development of synthetic TSH antagonists. Pept Res. 1995 Sep-Oct; 8(5):264-71.
    View PubMed
  107. Seetharamaiah GS, Wagle NM, Morris JC, Prabhakar BS. Generation and characterization of monoclonal antibodies to the human thyrotropin (TSH) receptor: antibodies can bind to discrete conformational or linear epitopes and block TSH binding. Endocrinology. 1995 Jul; 136(7):2817-24.
    View PubMed
  108. Levine JA, Morris JC. The use of a football helmet to secure a nasogastric tube. Nutrition. 1995 May-Jun; 11(3):285.
    View PubMed
  109. Nagy EV, Morris JC, Burch HB, Bhatia S, Salata K, Burman KD. Thyrotropin receptor T cell epitopes in autoimmune thyroid disease. Clinical Immunology & Immunopathology. 1995 May; 75(2):117-24.
    View PubMed
  110. Bryant WP, Bergert ER, Morris JC. Identification of thyroid blocking antibodies and receptor epitopes in autoimmune hypothyroidism by affinity purification using synthetic TSH receptor peptides. Autoimmunity. 1995; 22(2):69-79.
    View PubMed
  111. Wagle NM, Dallas JS, Morris JC, Prabhakar BS. Thyrotropin receptor specific antibodies in BALB/cJ mice with experimental hyperthyroxinemia show a restricted binding specificity and belong to the IgG1 subclass. 6 1995 Endocrinology 13; 136:3461-9.
  112. Bryant WP, Bergert ER, Morris JC. Delineation of amino acid residues with hTSHr 256-275 that participate in hormone binding. J Biol Chem. 1994 Dec 9; 269:30935-8.
    View PubMed
  113. Oda RP, Madden BJ, Morris JC, Spelsberg TC, Landers JP. Multiple-buffer-additive strategies for enhanced capillary electrophoretic separation of peptides. J Chromatogr A. 1994 Sep 30; 680(1):341-51.
    View PubMed
  114. Dallas JS, Desai RK, Cunningham SJ, Morris JC, Seetharamaiah GS, Wagle N, Goldblum RM, Prabhakar BS. Thyrotropin (TSH) interacts with multiple discrete regions of the TSH receptor: polyclonal rabbit antibodies to one or more of these regions can inhibit TSH binding and function. Endocrinology. 1994 Mar; 134(3):1437-45.
    View PubMed
  115. Morris JC, Gibson JL, Haas EJ, Bergert ER, Dallas JS, Prabhakar BS. Identification of epitopes and affinity purification of thyroid stimulating auto-antibodies using synthetic human TSH receptor peptides. Autoimmunity. 1994; 17(4):287-99.
    View PubMed
  116. Morris JC, Bergert ER, McCormick DJ. Structure-function studies of the human thyrotropin receptor. Inhibition of binding of labeled thyrotropin (TSH) by synthetic human TSH receptor peptides. J Biol Chem. 1993 May 25; 268(15):10900-5.
    View PubMed
  117. Leinung MC, Bergert ER, McCormick DJ, Morris JC. Synthetic analogs of the carboxyl-terminus of beta-thyrotropin: the importance of basic amino acids in receptor binding activity. Biochemistry. 1992 Oct 20; 31(41):10094-8.
    View PubMed
  118. Nagy EV, Burch HB, Mahoney K, Lukes YG, Morris JC 3rd, Burman KD. Graves' IgG recognizes linear epitopes in the human thyrotropin receptor. Biochem Biophys Res Commun. 1992 Oct 15; 188(1):28-33.
    View PubMed
  119. Freeman SL, McCormick DJ, Ryan RJ, Morris JC. Inhibition of TSH bio-activity by synthetic beta TSH peptides. Endocr Res. 1992; 18(1):1-17.
    View PubMed
  120. Leinung MC, Reed DK, McCormick DJ, Ryan RJ, Morris JC. Further characterization of the receptor-binding region of the thyroid-stimulating hormone alpha subunit: a comprehensive synthetic peptide study of the alpha-subunit 26-46 sequence. Proc Natl Acad Sci U S A. 1991 Nov 1; 88(21):9707-11.
    View PubMed
  121. Cole LA, Kardana A, Andrade-Gordon P, Gawinowicz MA, Morris JC, Bergert ER, O'Connor J, Birken S. The heterogeneity of human chorionic gonadotropin (hCG). III. The occurrence and biological and immunological activities of nicked hCG. Endocrinology. 1991 Sep; 129(3):1559-67.
    View PubMed
  122. Charlesworth MC, Bergert ER, Morris JC, McCormick DJ, Ryan RJ. The antigenic structure of the human glycoprotein hormone alpha-subunit: III. Solution- and solid-phase mapping using synthetic peptides. Endocrinology. 1991 Jun; 128(6):2907-15.
    View PubMed
  123. Morris JC, McCormick DJ, Ryan RJ. Inhibition of thyrotropin binding to receptor by synthetic human thyrotropin beta peptides. J Biol Chem. 1990 Feb 5; 265(4):1881-4.
    View PubMed
  124. Morris JC 3rd, Jiang NS, Hay ID, Charlesworth MC, McCormick DJ, Ryan RJ. The effects of synthetic alpha-subunit peptides on thyroid-stimulating immunoglobulin activity. J Clin Endocrinol Metab. 1988 Oct; 67(4):707-12.
    View PubMed
  125. Morris JC 3rd, Ranganathan G, Hay ID, Nelson RE, Jiang NS. The effects of transforming growth factor-beta on growth and differentiation of the continuous rat thyroid follicular cell line, FRTL-5. Endocrinology. 1988 Sep; 123(3):1385-94.
    View PubMed
  126. Morris JC 3rd, Hay ID, Nelson RE, Jiang NS. Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods. Mayo Clin Proc. 1988 Jul; 63(7):707-17.
    View PubMed
  127. Morris JC 3rd, Jiang NS, Charlesworth MC, McCormick DJ, Ryan RJ. The effects of synthetic alpha-subunit peptides on thyrotropin interaction with its receptor. Endocrinology. 1988 Jul; 123(1):456-62.
    View PubMed